Mood Disorders News

Patients with pulmonary fibrosis who used a smartphone app that offers cognitive behavioral therapy showed improvements in anxiety levels and quality of life, according to a press release.

Jazz Pharmaceuticals’ experimental PTSD treatment failed to meet the primary endpoint in a phase 2 trial, the company announced in a press release.

Focusing on mental health is one of the most popular New Year’s resolutions U.S. adults are making for 2024, according to a press release from the American Psychiatric Association.

Repeated withdrawal from contraceptive steroids during monthly pill pause was linked to adverse mental health symptoms, according to study findings published in JAMA Network Open.

AbbVie Inc. has acquired Cerevel Therapeutics and its pipeline of clinical stage and preclinical neuroscience candidates in development to address conditions such as Parkinson’s disease, schizophrenia and mood disorders.

ORLANDO — Self-managing programs to address comorbidities in patients with epilepsy require more education and independence from the creators, according to a poster.

Long-term treatment with psychedelics holds the potential to transform the health care industry through millions in savings, according to an expert at a congressional briefing hosted by Johns Hopkins University.

Neural markers can reliably distinguish mania/hypomania-specific risk from depression-specific risk in young adults, according to a study published in JAMA Psychiatry.

NEW ORLEANS — Optometrists are in a unique position to help identify mental health conditions in patients, according to optometrist turned licensed psychotherapist Dennis Pardo, OD, MPH, FAAO, LCSW, MSW.

NEW ORLEANS — Former NFL wide receiver and longtime mental health advocate Brandon Marshall emphasized the importance of maintaining mental health and shared his methods for staying mentally “fit.”